Sen. Lee Floats Bill To Drop Biosimilar Hurdle
A new U.S. Senate bill looks to reduce barriers to the introduction of cheaper generic counterparts for expensive brand-name biologic drugs by eliminating the need for so-called "switching studies," which examine the...To view the full article, register now.
Already a subscriber? Click here to view full article